Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Immunovia

0.22 SEK

-1.58 %

Less than 1K followers

IMMNOV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Immunovia

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.20.40.90.10.10.10.40.7
EBITDA-23.7-28.8-96.0-18.0-19.7-24.6-15.7-78.1
EBIT-31.2-30.1-109.4-18.9-20.1-25.1-16.4-80.4
EBIT-%-13,012.5 %-6,843.2 %-11,764.5 %-13,507.1 %-22,277.8 %-25,050.0 %-4,550.0 %-11,650.7 %
Profit before taxes-51.13.1-76.5-57.8-41.1-29.7-17.3-145.9
Net income-51.13.1-76.5-57.8-41.1-29.7-17.3-145.9
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.